This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

VIVUS Announces Scientific Presentations

Stocks in this article: VVUS

MOUNTAIN VIEW, Calif., Nov. 12, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing Qsymia ® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today announced the following scientific presentations in connection with Obesity Week 2013:


Early Development Pharmacologic and Device Session for Up and Coming Obesity Treatments


Tuesday, November 12, 2013, 12:00 pm - 1:30 pm

Georgia World Congress Center, Room A404-A405


Obesity Week 2013: First Annual Obesity Week: A collaboration of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS)

November 11-16, 2013

Georgia World Congress Center, Atlanta, GA


Oral Presentation Date: November 14, 2013 from 3:00 PM to 4:30 PM

Session Location: Georgia World Congress Center, A404-A405

Abstract number: T-35-OR

Presentation Title

Depression and Weight Loss Over 2 Years in Obese and Overweight Subjects Receiving Phentermine and Topiramate Extended-Release

Authors: Patrick M. O'Neil, PhD a; Craig Peterson, MS b

Affiliations: aMedical University of South Carolina, Charleston, SC; bVIVUS, Inc., Mountain View, CA


Oral Presentation Date: Friday, November 15, 2013 from 4:30 to 4:45pm

Session Location: Georgia World Congress Center, A402-A403

Presentation Title

Evaluation of Phentermine and Topiramate vs. Phentermine/Topiramate Extended-Release in Obese Adults

Authors: Louis J. Aronne, MD a; Thomas A. Wadden, PhD b; Craig Peterson, MS c; David Winslow, MD d; Sarah Odeh, BS, CMPP c, and Kishore M. Gadde, MD e

Affiliations: aWeill Cornell Medical College, New York, NY; bPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA; cVIVUS, Inc., Mountain View, CA; dKentucky Research Group, Louisville, KY; eDuke University Medical Center, Durham, NC


Poster Presentation Date: November 14, 2013

  • Poster viewing: 10:00am - 3:30pm and 5:30pm - 7:00pm
  • Authors present posters: 5:30pm - 7:00pm

Session Location: Georgia World Congress Center, Exhibit Hall A

1 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,062.39 +8.68 0.05%
S&P 500 2,093.07 +4.30 0.21%
NASDAQ 4,809.58 +2.7210 0.06%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs